DALPICICLIB

Clinical trials for DALPICICLIB explained in plain language.

Never miss a new study

Get alerted when new DALPICICLIB trials appear

Sign up with your email to follow new studies for DALPICICLIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for early breast cancer: drug combo aims to stop recurrence

Disease control Recruiting now

This study is testing whether adding the drug dalpiciclib to standard hormone therapy can help keep early-stage HR+/HER2- breast cancer from returning. About 2000 women with stage II or III breast cancer will receive either a lower dose for 3 years or a higher dose for 2 years. T…

Matched conditions: DALPICICLIB

Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control

Last updated May 22, 2026 14:02 UTC

DALPICICLIB

Get alerted when new DALPICICLIB trials appear

New hope for early breast cancer: drug combo aims to stop recurrence